Rosacea

Journal of Midwifery and Women's Health

Volumn 57, Issue 4, 2012, Pages 403-409

  Fuller, Dianne ^a   Martin, Suzanne ^a  

^a NONE   (United States)

Author keywords

Dermatological condition; Pharmacotherapy; Rosacea

Indexed keywords

AZELAIC ACID; DOXYCYCLINE; IBUPROFEN; LORATADINE; METRONIDAZOLE; SALBUTAMOL; SUNSCREEN;

ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; BEDTIME DOSAGE; CASE REPORT; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECZEMA; EMOTION; ERYTHEMA; FACE RASH; FEMALE; HUMAN; LOW DRUG DOSE; MIGRAINE; PATIENT EDUCATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; ROSACEA; SKIN TINGLING; SOCIAL SUPPORT; SUNLIGHT PROTECTION; WINE;

EID: 84863533684     PISSN: 15269523     EISSN: 15422011     Source Type: Journal    
DOI: 10.1111/j.1542-2011.2011.00156.x     Document Type: Article

References (34)

1. Korting HC, Schollman C. Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol. 2009;23:876-882.
2. Powell FC. Rosacea. N Engl J Med. 2005;352:793-803.
3. Webster GF. Rosacea. Med Clin North Am. 2009;93:1183-1194.
4. Abram K, Silm H, Oona M. Prevalence of rosacea in an Estonian working population using a standard classification. Acta Derm Venereo. 2010;90(3):269-273.
5. Del Rosso JQ, Webster GF, Kackson M, et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol. 2007;56:791-802.
6. Aksoy B, Altaykan-Hapa A, Egemen D, Karago F, Atakan N. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol. 2010;163(4):719-725.
7. Oltz M, Check J. Rosacea and its ocular manifestations. Optometry. 2011;82:92-103.
8. McAleer MA, Fitzpatrick P, Powell FC. Papulopustular rosacea: prevalence and relationship to photodamage. J Am Acad Dermatol. 2010;63(1):33-39.
9. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69(5):419-423.
10. Ferahbas A, Utas S, Mistik S, Uksal U, Peker D. Rosacea fulminans in pregnancy: case report and review of the literature. Am J Clin Dermatol. 2006;7(2):141-144.
11. Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2004;50:907-912.
12. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005.
13. Neuhaus I, Zane LT, Tope WD. Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea. Dermatol Surg. 2009;35:920-928.
14. Tan R, Tope WD. Pulsed dye laser treatment of rosacea improves erythema, symptomology, and quality of life. J Am Acad Dermatol. 2004;51:592-599.
15. van Zuuren EJ, Gupta AK, Gover MD, Graver M, Hollis S. Systematic review of rosacea treatments. J Am Acad Dermatol. 2007;56:107-115.
16. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol. 1999;40:961-965.
17. Elewski BE, Fleischer AB, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol. 2003;139:1444-1450.
18. Sanchez J, Lugo-Somolinos A, Almodo P, Webster G, Bradshaw M. A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea. J Am Acad Dermatol. 2005;53(5):791-797.
19. Boastanci O, Borelli C, Schaller M. Treatment of extrafacial rosacea with low-dose isotretinoin. Acta Derm Venereol. 2010;90(4):409-410.
20. Erdogan FG, Yurtsever P, Aksoy D, Eskioglu F. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol. 1998;134(7):884-885.
21. Gollnick H, Blume-Peytavi U, Szabo EL, et al. Systemic isotretinoin in the treatment of rosacea-doxycycline- and placebo-controlled, randomized clinical study [German]. J Dtsch Dermatol Ges. 2010;8:505-514.
22. Schechter BA, Katz RS, Friedman LS. Efficacy of topical cyclosporine for the treatment of ocular rosacea. Adv Ther. 2009;26:651-659.
23. Rubin M, Rao SN. Efficacy of topical cyclosporine 0.05% in the treatment of posterior blepharitis. J Ocul Pharmacol Ther. 2006;22:47-53.
24. Brignole-Baudouin F, Baudouin C, Aragona P, et al. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol. 2011;89(7):e591-e597.
25. McAleer MA, Powell FC. Complementary and alternative medicine usage in rosacea. Br J Dermatol. 2008;158:1139-1141.
26. Chen Y, Chang JS. Complementary and alternative medicine use among patients attending a hospital dermatology clinic in Taiwan. Int J Dermatol. 2003;42:616-621.
27. Berg M, Arnetz B. Characteristics of users and nonusers of alternative medicine in consecutive sample of patients with systemic lupus erythematosus. J Rheumatol. 1997;24:2490-2491.
28. Baron SE, Goodwin RG, Nicolau N. Use of complementary medicine among outpatients with dermatologic conditions within Yorkshire and South Wales, United Kingdom. J Am Acad Dermatol. 2005;52:589-594.
29. Wu J. Treatment of rosacea with herbal ingredients. J Drugs Dermatol. 2006;5(1):29-32.
30. Weber TM, Ceilley RI, Buerger A, et al. Skin tolerance, efficacy, and quality of life in patients with red facial skin using a skin care regiment containing Licochalcone A. J Cosmet Dermatol. 2006;5(3):227-232.
31. Sur R, Martin K, Liebel F, Lyte P, Shapiro S, Southall M. Anti-inflammatory activity of parthenolide-depleted feverfew (tanacetum parthenium). Inflammopharmacology. 2009;17(1):42-49.
32. Heinrich U, Moore CE, Spirt SD, Tronnier H, Stahl W. Green tea polyphenols provide photoprotection, increase microcirculation, and modulate skin properties of women. J Nutr. 2011;141:1202-1208.
33. National Rosacea Society. New survey maps emotional toll of rosacea as severity increases. Rosacea Review. 2007;Spring:2;article 3.
34. National Rosacea Society. Rosacea takes toll on sufferers in the workplace, Survey Shows. Rosacea Review. 2011;Summer:2; article 3.